Interview with Sarat Chandarlapaty, MD, PhD, author of Prevalence of ESR1 Mutations in Cell-Free DNA and Outcomes in Metastatic Breast Cancer: A Secondary Analysis of the BOLERO-2 Clinical Trial
don't worry if you don't have an account with us, we'll create one
[{"meta":{"author":"JAMA Oncology Author Interviews","authorlink":""},"src":"http:\/\/traffic.libsyn.com\/jamaoncologyauthorinterviews\/ESR1_Mutations_in_Metastatic_Breast_Cancer_JAMA_Oncology.mp3?dest-id=422099","thumb":{"src":"https:\/\/images.lystnfm.com\/tr:n-app_thumbnail_medium\/podcastsnw-202106\/9e98c8-7374-7bac-581724_800.jpg"},"title":"ESR1 Mutations in Metastatic Breast Cancer","link":"javascript:;","id":"item-438016"}]
